• Users Online: 180
  • Print this page
  • Email this page
ORIGINAL ARTICLES
Year : 2022  |  Volume : 10  |  Issue : 3  |  Page : 164-175

In-vivo evaluation of chondroprotective activity of Ariflex tablet in comparison with aceclofenac tablet and chondroitin sulfate/glucosamine (CG) in monosodium iodoacetate-induced osteoarthritis in rats


1 Ari Healthcare Pvt. Ltd, Office at No. 107, 1st Floor, S. No. 1, World Trade Center, Tower One, Opp. EON SEZ, Kharadi, Pune 411014, Maharashtra, India
2 Marathwada Mitra Mandal’s College of Pharmacy, S. No. 4/17, Sector-34, PCNTDA, Theragoan, Pune 411033, Maharashtra, India

Correspondence Address:
Sanjay U Nipanikar
Ari Healthcare Pvt. Ltd, Office at No. 107, 1st Floor, S. No. 1, World Trade Center, Tower One, Opp. EON SEZ, Kharadi, Pune 411014, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jism.jism_49_22

Rights and Permissions

Background: Degenerative changes in a joint subsequent to alterations in cartilage formation equilibrium lead to development of osteoarthritis (OA). Aims: Chondroprotective activity of Ariflex tablet (a polyherbal formulation) was evaluated in comparison with chondroitin/glucosamine and aceclofenac in monosodium iodoacetate-induced OA in Wistar rat models. Materials and Methods: A total of 42 animals were divided into seven groups, viz., four control groups [negative, positive, standard and vehicle controls] and three test groups [low, medium, and high dosages]. Animals in seven groups were treated with various study drugs for the period of 28 days. In this study period, measurement of body weight and knee joint swelling was done periodically. Gait score was recorded on the last day, and histopathological examination of joints was done after sacrificing the animals. Results: Chondroprotective activity of medium and high dose of Ariflex tablet was comparable to that of aceclofenac and superior to chondroitin + glucosamine combination. In few rats of medium and high dose of Ariflex tablet groups, chondrocyte regeneration and formation of new blood vessels were seen, which indicated possibility of chondrocyte regeneration activity of Ariflex tablet. Conclusion: Ariflex tablet possesses significant chondroprotective activity comparable to aceclofenac and superior to chondroitin and glucosamine combination. There was a possibility of chondrocyte regeneration activity of Ariflex tablet, which can be confirmed by conducting another study with long-term treatment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed414    
    Printed18    
    Emailed0    
    PDF Downloaded62    
    Comments [Add]    

Recommend this journal